［1］ JIANG D,ZHANG L,LIU W,et al.Trends in cancer mortality in China from 2004 to 2018:A nationwide longitudinal study ［J］.Cancer Commun (Lond),2021,41(10):1024-1036.
［2］ DIEU-NOSJEAN MC,GOC J,GIRALDO NA,et al.Tertiary lymphoid structures in cancer and beyond ［J］.Trends Immunol,2014,35(11):571-580.
［3］ SILINA K,SOLTERMANN A,ATTAR FM,et al.Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma ［J］.Cancer Res,2018,78(5):1308-1320.
［4］ SATO Y,SILINA K,VAN DEN BROEK M,et al.The roles of tertiary lymphoid structures in chronic diseases ［J］.Nat Rev Nephrol,2023,19(8):525-537.
［5］ WU YH,WU F,YAN GR,et al.Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma ［J］.J Eur Acad Dermatol Venereol,2022,36(11):2043-2050.
［6］ LIANG H,ZHANG Z,GUAN Z,et al.Follicle-like tertiary lymphoid structures:A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma ［J］.Front Immunol,2023,14:1096220.
［7］ LI Q,LIU X,WANG D,et al.Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma ［J］.Int J Oral Sci,2020,12(1):24.
［8］ YAMAGUCHI K,ITO M,OHMURA H,et al.Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer ［J］.Oncoimmunology,2020,9(1):1724763.
［9］ SEOW DYB,YEONG JPS,LIM JX,et al.Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers ［J］.Breast Cancer Res Treat,2020,180(2):369-377.
［10］ DIEU-NOSJEAN MC,GIRALDO NA,KAPLON H,et al.Tertiary lymphoid structures,drivers of the anti-tumor responses in human cancers ［J］.Immunol Rev,2016,271(1):260-275.
［11］ HIRAOKA N,INO Y,YAMAZAKI-ITOH R.Tertiary lymphoid organs in cancer tissues ［J］.Front Immunol,2016,7:244.
［12］ SAUTES-FRIDMAN C,PETITPREZ F,CALDERARO J,et al.Tertiary lymphoid structures in the era of cancer immunotherapy ［J］.Nat Rev Cancer,2019,19(6):307-325.
［13］ SCHUMACHER TN,THOMMEN DS.Tertiary lymphoid structures in cancer ［J］.Science,2022,375(6576):eabf9419.
［14］ ZHAO H,WU L,YAN G,et al.Inflammation and tumor progression:signaling pathways and targeted intervention ［J］.Signal Transduct Target Ther,2021,6(1):263.
［15］ DIEU-NOSJEAN MC,ANTOINE M,DANEL C,et al.Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures ［J］.J Clin Oncol,2008,26(27):4410-4417.
［16］ GOC J,GERMAIN C,VO-BOURGAIS TK,et al.Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells ［J］.Cancer Res,2014,74(3):705-715.
［17］ COSGROVE J,NOVKOVIC M,ALBRECHT S,et al.B cell zone reticular cell microenvironments shape CXCL13 gradient formation ［J］.Nat Commun,2020,11(1):3677.
［18］ BLANCHARD L,GIRARD JP.High endothelial venules (HEVs) in immunity,inflammation and cancer ［J］.Angiogenesis,2021,24(4):719-753.
［19］ RUDDLE NH.High endothelial venules and lymphatic vessels in tertiary lymphoid organs:characteristics,functions,and regulation ［J］.Front Immunol,2016,7:491.
［20］ KRAUTLER NJ,KANA V,KRANICH J,et al.Follicular dendritic cells emerge from ubiquitous perivascular precursors ［J］.Cell,2012,150(1):194-206.
［21］ DE CHAISEMARTIN L,GOC J,DAMOTTE D,et al.Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer ［J］.Cancer Res,2011,71(20):6391-6399.
［22］ GERMAIN C,GNJATIC S,TAMZALIT F,et al.Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer ［J］.Am J Respir Crit Care Med,2014,189(7):832-844.
［23］ NZULA S,GOING JJ,STOTT DI.Antigen-driven clonal proliferation,somatic hypermutation,and selection of B lymphocytes infiltrating human ductal breast carcinomas ［J］.Cancer Res,2003,63(12):3275-3280.
［24］ ZHU W,GERMAIN C,LIU Z,et al.A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality ［J］.Oncoimmunology,2015,4(12):e1051922.
［25］ JOHANSSON-PERCIVAL A,HE B,LI ZJ,et al.De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors ［J］.Nat Immunol,2017,18(11):1207-1217.
［26］ GERMAIN C,GNJATIC S,DIEU-NOSJEAN MC.Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity ［J］.Front Immunol,2015,6:67.
［27］ BANNARD O,HORTON RM,ALLEN CD,et al.Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection ［J］.Immunity,2013,39(5):912-924.
［28］ ALLEN CD,OKADA T,CYSTER JG.Germinal-center organization and cellular dynamics ［J］.Immunity,2007,27(2):190-202.
［29］ LING Y,ZHONG J,WENG Z,et al.The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma ［J］.Clin Transl Med,2022,12(10):e1074.
［30］ HOREWEG N,WORKEL HH,LOIERO D,et al.Tertiary lymphoid structures critical for prognosis in endometrial cancer patients ［J］.Nat Commun,2022,13(1):1373.
［31］ POWELL SF,VU L,SPANOS WC,et al.The key differences between human papillomavirus-positive and-negative head and neck cancers:biological and clinical implications ［J］.Cancers,2021,13(20):5206.
［32］ RUFFIN AT,CILLO AR,TABIB T,et al.B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma ［J］.Nat Commun,2021,12(1):3349.
［33］ J GUNDERSON A,RAJAMANICKAM V,BUI C,et al.Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden,humoral immunity and long-term survivorship in pancreatic cancer ［J］.Oncoimmunology,2021,10(1):1900635.
［34］ POSCH F,SILINA K,LEIBL S,et al.Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer ［J］.Oncoimmunology,2018,7(2):e1378844.
［35］ DING GY,MA JQ,YUN JP,et al.Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma ［J］.J Hepatol,2022,76(3):608-618.
［36］ MASUDA T,TANAKA N,TAKAMATSU K,et al.Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma:prognostic outcome and comparison with bladder cancer ［J］.J Immunother Cancer,2022,10(3):e003883.
［37］ LIU X,TSANG JYS,HLAING T,et al.Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers ［J］.Oncologist,2017,22(11):1316-1324.
［38］ DI CARO G,BERGOMAS F,GRIZZI F,et al.Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers ［J］.Clin Cancer Res,2014,20(8):2147-2158.
［39］ MORCRETTE G,HIRSCH TZ,BADOUR E,et al.APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures ［J］.Oncoimmunology,2019,8(6):e1583547.
［40］ CALDERARO J,PETITPREZ F,BECHT E,et al.Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma ［J］.J Hepatol,2019,70(1):58-65.
［41］ CABRITA R,LAUSS M,SANNA A,et al.Tertiary lymphoid structures improve immunotherapy and survival in melanoma ［J］.Nature,2020,577(7791):561-565.
［42］ KROEGER DR,MILNE K,NELSON BH.Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures,cytolytic T-cell responses,and superior prognosis in ovarian cancer ［J］.Clin Cancer Res,2016,22(12):3005-3015.
［43］ KUWABARA S,TSUCHIKAWA T,NAKAMURA T,et al.Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma ［J］.Cancer Sci,2019,110(6):1853-1862.
［44］ PETITPREZ F,DE REYNIES A,KEUNG EZ,et al.B cells are associated with survival and immunotherapy response in sarcoma ［J］.Nature,2020,577(7791):556-560.
［45］ FRIDMAN WH,PETITPREZ F,MEYLAN M,et al.B cells and cancer:To B or not to B［J］.J Exp Med,2021,218(1):e20200851.
［46］ RIBAS A,WOLCHOK JD.Cancer immunotherapy using checkpoint blockade ［J］.Science,2018,359(6382):1350-1355.
［47］ HELMINK BA,REDDY SM,GAO J,et al.B cells and tertiary lymphoid structures promote immunotherapy response ［J］.Nature,2020,577(7791):549-555.
［48］ MOUNZER RH,SVENDSEN OS,BALUK P,et al.Lymphotoxin-alpha contributes to lymphangiogenesis ［J］.Blood,2010,116(12):2173-2182.
［49］ ZHANG Q,LU Y,PROULX ST,et al.Increased lymphangiogenesis in joints of mice with inflammatory arthritis ［J］.Arthritis Res Ther,2007,9(6):R118.
［50］ LEE Y,CHIN RK,CHRISTIANSEN P,et al.Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure ［J］.Immunity,2006,25(3):499-509.
［51］ LUTHER SA,LOPEZ T,BAI W,et al.BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis ［J］.Immunity,2000,12(5):471-481.
［52］ LUTHER SA,BIDGOL A,HARGREAVES DC,et al.Differing activities of homeostatic chemokines CCL19,CCL21,and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis ［J］.J Immunol,2002,169(1):424-433.
［53］ STOWMAN AM,HICKMAN AW,MAULDIN IS,et al.Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures ［J］.Melanoma Res,2018,28(3):237-245.
［54］ 章杭,沈晓燕,杨杨,等.三级淋巴结构在非小细胞肺癌中的研究进展［J］.现代肿瘤医学，2017,25(13):2183-2186.
ZHANG Hang,SHEN Xiaoyan,YANG Yang,et al.Advances of tertiary lymphoid structures in non-small cell lung cancer［J］.Modern Oncology,2017,25(13):2183-2186.
［55］ KABASHIMA K,HONDA T,GINHOUX F,et al.The immunological anatomy of the skin ［J］.Nat Rev Immunol,2019,19(1):19-30.
［56］ JACOBSON A,YANG D,VELLA M,et al.The intestinal neuro-immune axis:crosstalk between neurons,immune cells,and microbes ［J］.Mucosal Immunol,2021,14(3):555-565.
［57］ FRIDMAN WH,SIBERIL S,PUPIER G,et al.Activation of B cells in tertiary lymphoid structures in cancer:Anti-tumor or anti-self ［J］.Semin Immunol,2023,65:101703.